Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Ralph Dornburg"'
Autor:
Roger J. Pomerantz, Ralph Dornburg, Muhammad Mukhtar, Zahida Parveen, David S. Strayer, Elena Marusich
Publikováno v:
Virology. 332(1):258-271
In this study, we report on the efficacy of using a spleen necrosis virus (SNV)-based vector delivery system to block human immunodeficiency virus type I (HIV-1) replication in human hematopoietic cells. These efforts were directed towards the develo
Publikováno v:
Molecular Therapy. 9(4):557-565
RNA splicing is a complex event in the retroviral life cycle and can involve multiple steps, as well as cis-acting sequences, to maintain a proper balance of spliced and unspliced viral RNA for translation and encapsidation. The retroviral RNA can be
Publikováno v:
Frontiers in Bioscience. 8:s156-174
Lentiviruses belong to a subfamily of the retroviruses usually associated with persistent infections in animals and humans. They have complex replication cycles involving numerous regulatory and accessory proteins, which sets them apart from the onco
Autor:
Ralph Dornburg
Publikováno v:
Frontiers in Bioscience. 8:d818-835
Retrovirus-derived gene transfer systems (retroviral vectors) are the most commonly used gene transfer tools in modern biology. They have been used to study various aspects of retroviral replication, the organization and function of oncogenes and oth
Publikováno v:
Scopus-Elsevier
The method of delivering a therapeutic gene into a patient is still one of the major obstacles towards successful human gene therapy. Here we describe a novel gene delivery approach using TheraCyte immunoisolation devices. Retroviral vector producing
Autor:
Klaus Cichutek, Roger J. Pomerantz, Zahida Parveen, Anna Krupetsky, Ralph Dornburg, Martin Engelstädter
Publikováno v:
Nature Biotechnology. 18:623-629
Gene therapy applications of retroviral vectors derived from C-type retroviruses have been limited to introducing genes into dividing target cells. Here, we report genetically engineered C-type retroviral vectors derived from spleen necrosis virus (S
Autor:
Te-Hua Tearina Chu, Klaus Cichutek, Reinhard Kurth, Martin Engelstädter, Maria Bobkova, Ralph Dornburg, Michael Baier, Christian J. Buchholz, Nicola Holtkamp, Jörn Stitz
Publikováno v:
Human Gene Therapy. 11:293-303
To generate T cell-specific retroviral vectors an scFv phage display library derived from immunized mice was selected for binding to the human T cell line Molt-4/8. The scFv cDNAs recovered from the selected phages were transiently expressed as an N-
Publikováno v:
Human Gene Therapy. 10:2627-2636
We reported that SNV-derived retroviral vectors, which display single-chain antibodies on the viral surface, enable cell type-specific gene delivery into various human cells. In particular, the SNV cell type-specific gene delivery vector system appea
Publikováno v:
Journal of Virology. 72:10148-10156
The successful application of human gene therapy protocols on a broad clinical basis will depend on the availability of in vivo cell-type-specific gene delivery systems. We have developed retroviral vector particles, derived from spleen necrosis viru
Autor:
Ralph Dornburg, Idali Martinez
Publikováno v:
Human Gene Therapy. 7:705-712
Contamination of retroviral vector preparations with replication-competent retroviruses is a major safety concern in human gene therapy. These can arise by recombination between retroviral vectors and packaging cell sequences. Recently, we constructe